Tower Research Capital (TRC)’s Pyrophyte Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant PHYT.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100
Closed -$1.09K 6428
2023
Q3
$1.09K Buy
+100
New +$1.08K ﹤0.01% 5403

Other funds holding PHYT.U

Tower Research Capital (TRC)'s PHYT.U Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Pyrophyte Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (PHYT.U) in Q4 2023, closing a stake of 100 shares — an estimated $1.09K sold.

Tower Research Capital (TRC) first reported a position in PHYT.U in Q3 2023 and held it in 1 quarter. The position peaked at $1.09K in Q3 2023. 3 funds tracked by Wall St. Rank hold PHYT.U as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Pyrophyte Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 Pyrophyte Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2023, an estimated $1.09K.
  • Tower Research Capital (TRC) first reported a position in Pyrophyte Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q3 2023 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Pyrophyte Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $1.09K in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Pyrophyte Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.